ArticleInternational urology and nephrology2025

Application of extended immunotherapy in advanced clear cell renal cell carcinoma treated with first-line combination of immune-checkpoint inhibitor and tyrosine kinase inhibitor.

Qian Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.